ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors

https://repo.qst.go.jp/records/46205
https://repo.qst.go.jp/records/46205
304ccb39-ab9c-4b65-9a91-ca69e654133a
Item type 学術雑誌論文 / Journal Article(1)
公開日 2011-11-11
タイトル
タイトル Brain and whole-body imaging in rhesus monkeys of 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Kimura, Yasuyuki

× Kimura, Yasuyuki

WEKO 460095

Kimura, Yasuyuki

Search repository
et.al

× et.al

WEKO 460096

et.al

Search repository
木村 泰之

× 木村 泰之

WEKO 460097

en 木村 泰之

Search repository
抄録
内容記述タイプ Abstract
内容記述 Our laboratory developed 11C-NOP-1A, a new radioligand for the nociceptin/orphanin FQ peptide (NOP) receptor with high affinity (Ki = 0.15 nM) and appropriate lipophilicity (measured logD = 3.4) for PET brain imaging. Here, we assessed the utility of 11C-NOP-1A for quantifying NOP receptors in monkey brain and estimated the radiation safety profile of this radioligand based on its biodistribution in monkeys. Methods: Baseline and blocking PET scans were acquired from head to thigh on three rhesus monkeys for ~120 minutes after 11C-NOP-1A injection. These six PET scans were used to quantify NOP receptors in brain and to estimate radiation exposure to organs of the body. In the blocked scans, a selective nonradioactive NOP receptor antagonist (SB-612111; 1 mg/kg i.v.) was administered before 11C-NOP-1A. In all scans, arterial blood was sampled to measure the parent radioligand 11C-NOP-1A. Distribution volume (VT; a measure of receptor density) was calculated with a compartment model using brain and arterial plasma data. Radiation-absorbed doses were calculated using the Medical Internal Radiation Dose Committee scheme. Results: After 11C-NOP-1A injection, peak uptake of radioactivity in brain had a high concentration (~5 SUV), occurred early (~12 minutes), and thereafter washed out quickly. VT (mL · cm-3) was highest in neocortex (~20) and lowest in hypothalamus and cerebellum (~13). SB-612111 blocked ~50-70% of uptake and reduced VT in all brain regions to ~7 mL · cm-3. Distribution was well identified within 60 minutes of injection and stable for the remaining 60 minutes, consistent with only parent radioligand and not radiometabolites entering brain. Whole- body scans confirmed that the brain had specific (i.e., displaceable) binding but could not detect specific binding in peripheral organs. The effective dose for humans estimated from the baseline scans in monkeys was 5.0 microSv/MBq.
Conclusion: 11C-NOP-1A is a useful radioligand for quantifying NOP receptors in monkey brain, and its radiation dose is similar to that of other 11C-labeled ligands for neuroreceptors. 11C- NOP-1A appears to be a promising candidate for measuring NOP receptors in human brain.
書誌情報 Journal of Nuclear Medicine

巻 52, 号 10, p. 1638-1645, 発行日 2011-10
ISSN
収録物識別子タイプ ISSN
収録物識別子 0161-5505
DOI
識別子タイプ DOI
関連識別子 10.2967/jnumed.111.091181
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:54:37.393421
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3